New Developments in the pharmacotherapy of schizophrenia

The Effects of Risperidone on the Five Dimensions of Schizophrenia Derived by Factor Analysis

1997 • 705 citations

Efficacy and Safety of Aripiprazole and Haloperidol Versus Placebo in Patients With Schizophrenia and Schizoaffective Disorder

2002 • 624 citations

Efficacy of High-Dose Glycine in the Treatment of Enduring Negative Symptoms of Schizophrenia

1999 • 484 citations

Long-Acting Injectable Risperidone: Efficacy and Safety of the First Long-Acting Atypical Antipsychotic

2003 • 474 citations

A Placebo-Controlled Trial of D-Cycloserine Added to Conventional Neuroleptics in Patients With Schizophrenia

1999 • 435 citations

The Expert Consensus Guideline Series

2001 • 402 citations

A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms

2002 • 332 citations

Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia

2001 • 330 citations

Guidelines for depot antipsychotic treatment in schizophrenia

1998 • 329 citations

A Placebo-Controlled Trial of Omega-3 Fatty Acid (Ethyl Eicosapentaenoic Acid) Supplementation for Residual Symptoms and Cognitive Impairment in Schizophrenia

2001 • 327 citations

Double-Blind, Placebo-Controlled Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in the Treatment of Acute Agitation in Schizophrenia

2001 • 304 citations

Randomized, Placebo-Controlled Study of Ethyl-Eicosapentaenoic Acid as Supplemental Treatment in Schizophrenia

2002 • 303 citations

Sulpiride augmentation in people with schizophrenia partially responsive to clozapine

1997 • 261 citations

Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study

2003 • 252 citations

Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia

1995 • 238 citations

Oxidative stress and role of antioxidant and ω-3 essential fatty acid supplementation in schizophrenia

2001 • 232 citations

Effect of Divalproex Combined with Olanzapine or Risperidone in Patients with an Acute Exacerbation of Schizophrenia

2003 • 230 citations

Benzodiazepines in the treatment of schizophrenia: a review and reappraisal

1991 • 225 citations

Adjunctive high-dose glycine in the treatment of schizophrenia

2001 • 198 citations

The Expert Consensus Guideline Series. Treatment of behavioral emergencies.

2001 • 195 citations

The Effects of a Selective D4 Dopamine Receptor Antagonist (L-745,870) in Acutely Psychotic Inpatients With Schizophrenia

1997 • 195 citations

Recent Trends in Antipsychotic Combination Therapy of Schizophrenia and Schizoaffective Disorder: Implications for State Mental Health Policy

2002 • 190 citations

Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial

2001 • 176 citations

Somatic Treatment of Catatonia

1995 • 175 citations

Placebo-Controlled Trial of Glycine Added to Clozapine in Schizophrenia

2000 • 174 citations

A clinical trial of the effects of estrogen in acutely psychotic women

1996 • 164 citations

Ritanserin, a Selective 5-HT_2/1C Antagonist, and Negative Symptoms in Schizophrenia

1993 • 153 citations

Pharmacologic strategies for augmenting cognitive performance in schizophrenia

1999 • 142 citations

Effect of Clozapine and Adjunctive High-Dose Glycine in Treatment-Resistant Schizophrenia

1999 • 140 citations

A Double-Blind, Controlled Comparison of the Novel Antipsychotic Olanzapine versus Haloperidol or Placebo on Anxious and Depressive Symptoms Accompanying Schizophrenia

1998 • 136 citations

Intramuscular Preparations of Antipsychotics

2003 • 117 citations

d-Cycloserine added to risperidone in patients with primary negative symptoms of schizophrenia

2002 • 110 citations

Polypharmacy in psychiatric treatment. Patterns of psychotropic drug use in Austrian psychiatric clinics

1999 • 105 citations

Aripiprazole

2002 • 100 citations

Differential effects of the D1-DA receptor antagonist SCH39166 on positive and negative symptoms of schizophrenia

1995 • 93 citations

Hormone replacement therapy in postmenopausal women with schizophrenia: positive effect on negative symptoms?

2001 • 82 citations

"Real World" Atypical Antipsychotic Prescribing Practices in Public Child and Adolescent Inpatient Settings

2002 • 81 citations

The pharmacological treatment of catatonia: an overview

2001 • 79 citations

Differential diagnosis of depressed mood in patients with schizophrenia: a diagnostic algorithm based on a review

2002 • 72 citations

Effects of risperidone on affective symptoms in patients with schizophrenia

2000 • 70 citations

Critical Review of GABA-ergic Drugs in the Treatment of Schizophrenia

1999 • 69 citations

A clinical trial of adjunctive oestrogen treatment in women with schizophrenia

2002 • 65 citations

Oestrogen effects in schizophrenia and their potential therapeutic implications - Review

2002 • 64 citations

Glycine modulators in schizophrenia.

2002 • 63 citations

Patterns of drug treatment of schizophrenic patients in Estonia, Spain and Sweden.

1995 • 60 citations

Dopamine agonists in schizophrenia: a review

1995 • 59 citations

Amisulpride improves depressive symptoms in acute exacerbations of schizophrenia: comparison with haloperidol and risperidone

2002 • 53 citations

[Pharmaco-epidemiological study on antipsychotic drug prescription in French Psychiatry: Patient characteristics, antipsychotic treatment, and care management for schizophrenia].

2002 • 46 citations

Östradiol hemmt Dopamin-vermittelte Verhaltensweisen bei Ratten - ein Tiermodell zur Untersuchung der geschlechtsspezifischen Unterschiede bei der Schizophrenie

1992 • 38 citations

Lithium Augmentation Fails to Reduce Symptoms in Poorly Responsive Schizophrenic Outpatients

1999 • 35 citations

Benzodiazepines in the treatment of schizophrenia: an updated survey

1991 • 35 citations

Elevation of extracellular cortical noradrenaline may contribute to the antidepressant activity of zotepine: an in vivo microdialysis study in freely moving rats

1998 • 30 citations

A review of pramipexole and its clinical utility in Parkinson’s disease

2002 • 30 citations

Dose-Related Effects of Amisulpride on Five Dimensions of Psychopathology in Patients With Acute Exacerbation of Schizophrenia

2002 • 28 citations

Depression in Patients with Schizophrenia

2000 • 20 citations

Contrasting clozapine prescribing patterns in the east and west?

2000 • 14 citations

A pilot study of intramuscular ziprasidone in the short-term treatment of patients with acute exacerbation of schizophrenia

2000 • 14 citations

Long-term safety of long-acting risperidone microspheres

2002 • 13 citations

Wirken Östrogene antipsychotisch?

1994 • 10 citations

Long-acting injectable risperidone: Efficacy and safety

2002 • 6 citations

The Role of Neurotransmitter Receptors in the Adverse Effects of Antipsychotic Drugs

2000 • 5 citations

The Declaration of Madrid and Current Psychiatric Practice: Users' and Advocates' Views - Introduction

1999 • 5 citations

Glutamate Receptors in Schizophrenia and Antipsychotic Drugs

2000 • 5 citations

The Antipsychotic Effects of Sigma Drugs

2000 • 3 citations